FDA-TRACK is FDA's agency-wide performance management program that monitors, analyzes and reports key performance data and projects for FDA's program offices and cross-cutting initiatives.

FDA has established a wide array of guidance and regulations to help assure patients have access to high-quality over-the-counter and prescription medications that are safe and effective. CDER diligently works to ensure compliance through facility inspections, product testing, and other pre- and postmarket actions, including enforcement actions, in the United States and globally. This work includes oversight of clinical trials, commercial manufacturing of raw and finished products, compounded drugs, supply chain integrity, drug recalls, product labels, drug registration and listing, and post-market safety requirements.

For a complete list of CDER measures and their relevant FDA-TRACK dashboard, refer to the FDA-TRACK CDER Index.